CLSI M45A

Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline, M45-A

Clinical and Laboratory Standards Institute, 05/30/2006

Publisher: CLSI

File Format: PDF

$143.00$287.41

Description

Published:30/05/2006

Pages:76

CLSI M45A provides guidance to clinical microbiology laboratories for standardized susceptibility testing of infrequently isolated or fastidious bacteria that are not presently included in CLSI/NCCLS documents M2, M7, or M11. The tabular information in this document presents the most current information for drug selection, interpretation, and quality control for the infrequently isolated or fastidious bacterial pathogens included in this guideline.

More CLSI standard pdf

CLSI C34A2

Sweat Testing: Sample Collection and Quantitative Analysis; Approved Guideline, C34-A2

$114.00 $228.13

CLSI C39-A

A Designated Comparison Method for the Measurement of Ionized Calcium in Serum; Approved Standard, 39AE

$120.00 $241.91

CLSI MM04-A

Quality Assurance for Immunocytochemistry; Approved Guideline, MM04A

$124.00 $249.27

CLSI C37-A (R2018)

Preparation and Validation of Commutable Frozen Human Serum Pools as Secondary Reference Materials for Cholesterol Measurement Procedures; Approved Guideline, C37AE

$134.00 $268.43